A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without EmtricitabineMackenzie L. Cottrell, Angela D. M. Kashuba, Kuo H. Yang et al.|The Journal of Infectious Diseases|2016Cited by 303
Single and Multiple Dose Pharmacokinetics of Maraviroc in Saliva, Semen, and Rectal Tissue of Healthy HIV-Negative MenKevin C. Brown, Angela D. M. Kashuba, Nicholas J. Shaheen et al.|The Journal of Infectious Diseases|2011Cited by 86
Dolutegravir Pharmacokinetics in the Genital Tract and Colorectum of HIV-Negative Men After Single and Multiple DosingBenjamin N. Greener, Angela D. M. Kashuba, Kristine B. Patterson et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2013Cited by 62
Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV preventionMelanie R. Nicol, Angela D. M. Kashuba, Yuri Fedoriw et al.|The Journal of Clinical Pharmacology|2013Cited by 55
Tenofovir Diphosphate and Emtricitabine Triphosphate Concentrations in Blood Cells Compared With Isolated Peripheral Blood Mononuclear CellsJessica Adams, Angela D. M. Kashuba, Craig Sykes et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2012Cited by 48